Your browser doesn't support javascript.
loading
Effects of γ-Secretase Inhibitor DAPT on Inflammation-Induced White Matter Damage in Neonatal Mice / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 1083-1087, 2018.
Article Dans Chinois | WPRIM | ID: wpr-858285
ABSTRACT

OBJECTIVE:

To investigate the effect of γ-secretase inhibitor DAPT in inflammation-induced brain white matter injury in neonatal mice.

METHODS:

Sixty C57BL/10J neonatal mice are randomly divided into control group, control+DAPT (10 mg•kg-1) group, inflammation (LPS) group, LPS+DAPT group (inflammation exposure after 10 mg•kg-1 DAPT treatment). All neonatal mice were killed and brain was removed to the following observation and detectionat P5, the mRNA expression variation of IL-1β, IL-8,TNF-α,Hes1 and NICD by Real-time PCR methods. Oligodendrocytes were identified by immunofluorescence staining. Myelin basic protein (MBP) protein expression was detected by Western blot assay.

RESULTS:

LPS group showed brain injury characterized by inhibition of brain development. There were significant differences in mRNA expression of IL-1β, IL-8, TNF-α, Hes1 and NICD between LPS+DAPT group and LPS group (P<0.05), and the mRNA expression of IL-1β, IL-8,TNF-α,Hes1 and NICD in inflammation-treated were significantly increased than control group (P<0.05). The results showed more expression of MBP in LPS+DAPT group compared with LPS group (P<0.05). Compared with the blank control group, which was obviously decreased after 48 h of inflammation (P<0.05).

CONCLUSION:

Inflammation leads to abnormal of notch signal expression in neonatal mice, and which is shows inflammation involved in brain damage.Its mechanism is probably associated with the maturation of oligodendrocytes.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Pharmaceutical Journal Année: 2018 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Pharmaceutical Journal Année: 2018 Type: Article